Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Senescence and autophagy	13/99	2.3672230191703744E-15	1.3351137828120911E-12	0	0	34.42689120556001	1159.3964411052152	JUN;CDKN1A;CXCL8;SERPINB2;CDKN2A;SERPINE1;IL24;MAPK14;THBS1;GABARAP;IFNG;IFI16;CCL3
Interleukin-2 signaling pathway	24/847	3.0101111232303794E-12	8.48851336750967E-10	0	0	7.319946281255995	194.191177850244	CX3CR1;FCGBP;JUN;CXCL8;SERPINE1;IL24;ARAP2;NKG7;FURIN;KIR2DL1;MAPK14;PRSS23;NELL2;LDHB;ABLIM1;IFNG;PLAU;PPP2R2B;CCL3;FLNB;JAK3;LDLR;GBP1;BIRC3
Gastrin pathway	7/44	2.078922419697571E-9	3.9083741490314334E-7	0	0	40.40714908456844	807.7961325798182	JUN;CXCL8;SERPINB2;CDKN2A;SERPINE1;HBEGF;BIRC3
T cell receptor regulation of apoptosis	16/603	4.929783563317022E-8	5.753472989677046E-6	0	0	6.266893810335037	105.44290524179391	EGR1;JUN;CDKN1A;CXCL8;SERPINE2;CDKN2A;RHOC;MAPK14;CLK1;PNP;IFNG;IFI16;CCL3;MYBL2;GBP1;BIRC3
Chagas disease	8/104	5.100596622054119E-8	5.753472989677046E-6	0	0	17.93840579710145	301.20956990452106	JUN;CXCL8;IFNG;PPP2R2B;CCL3L3;SERPINE1;CCL3;MAPK14
EGFR1 pathway	9/152	7.038520192908701E-8	6.616208981334179E-6	0	0	13.664258818104972	225.04054266966995	CLK1;SELENBP1;CDKN1A;PNP;MME;PLAU;IGFBP3;MYBL2;HBEGF
p53 activity regulation	8/118	1.3678877000889878E-7	1.1021266612145559E-5	0	0	15.644268774703557	247.25497600768207	CDKN1A;CDKN2A;IGFBP3;SERPINE1;SESN2;SIAH1;MAPK14;THBS1
AP-1 transcription factor network	6/70	1.3592722795173588E-6	9.582869570597379E-5	0	0	19.783244680851062	267.24316933003996	EGR1;JUN;CXCL8;IFNG;PLAU;CDKN2A
E2F transcription factor network	6/74	1.8898091670928132E-6	1.1703316590897131E-4	0	0	18.615769712140175	245.33787507392182	CDKN1A;PLAU;CDKN2A;SERPINE1;MYBL2;WASF1
Bladder cancer	5/42	2.0750561331377892E-6	1.1703316590897131E-4	0	0	28.25462304409673	369.7265014059194	CDKN1A;CXCL8;CDKN2A;DAPK2;THBS1
ID regulation of gene expression	4/20	2.680321068927162E-6	1.374273711704472E-4	0	0	51.78125	664.3313770708211	CDKN1A;CXCL8;CDKN2A;THBS1
Regular glucocorticoid receptor pathway	6/82	3.4589501088805235E-6	1.625706551173846E-4	0	0	16.6494960806271	209.35984521342374	EGR1;CDKN1A;JUN;CXCL8;IFNG;MAPK14
TSP1-induced apoptosis in microvascular endothelial cell	3/8	6.669353467633975E-6	2.686796682675401E-4	0	0	123.0618556701031	1466.6496741086537	JUN;MAPK14;THBS1
Dissolution of fibrin clot	3/8	6.669353467633975E-6	2.686796682675401E-4	0	0	123.0618556701031	1466.6496741086537	SERPINB2;PLAU;SERPINE1
Fibroblast growth factor 1	4/26	8.082295562387204E-6	3.012116672371257E-4	0	0	37.64772727272727	441.4510238762915	CDKN1A;SERPINB2;PLAU;SERPINE1
Immune system	17/998	8.545011836514205E-6	3.012116672371257E-4	0	0	3.9500264053154512	46.09745143632157	EGR1;JUN;CDKN1A;GBP7;UBE2L6;KIR2DL1;MAPK14;KIR2DL3;KIR2DL4;AIM2;IFNG;FLNB;TLR5;FCGR1A;JAK3;GBP1;BIRC3
ATF2 transcription factor network	5/59	1.1418514477399644E-5	3.788260097207882E-4	0	0	19.34307992202729	220.1295580852784	JUN;CXCL8;IFNG;PLAU;MAPK14
CD40/CD40L signaling	4/31	1.6687556029356314E-5	5.228767555864978E-4	0	0	30.66820987654321	337.37629271966244	JUN;MAPK14;JAK3;BIRC3
HIF-1 transcriptional activity in hypoxia	5/66	1.9827432166663002E-5	5.885616706314702E-4	0	0	17.117342536669543	185.35418707565327	NT5E;JUN;SERPINE1;SLC2A1;FURIN
Interferon signaling	7/168	2.163096257213536E-5	6.099931445342171E-4	0	0	9.228143992519868	99.12304577285857	EGR1;GBP7;IFNG;UBE2L6;FLNB;FCGR1A;GBP1
Oncostatin M	9/311	2.608456840185267E-5	7.005569799354717E-4	0	0	6.418091841932902	67.73761098684693	SELENBP1;JUN;CDKN1A;CXCL8;SERPINB2;PLAU;SERPINE1;LDLR;TGM2
Interleukin-1 regulation of extracellular matrix	6/120	3.097040197124892E-5	7.939684868992905E-4	0	0	11.078387458006718	115.0211205356334	JUN;CXCL8;SERPINB2;IFNG;BIRC3;HBEGF
FRA pathway	4/37	3.423076487553643E-5	8.393978865131542E-4	0	0	25.08459595959596	257.92949230262207	JUN;CXCL8;PLAU;CDKN2A
Pathways in cancer	9/325	3.679152637528889E-5	8.64600869819289E-4	0	0	6.129364306579497	62.5822990108807	JUN;CDKN1A;CDKN2B;CXCL8;FLT3;CDKN2A;DAPK2;SLC2A1;BIRC3
BDNF signaling pathway	8/261	4.992797390274785E-5	0.0010791879451243283	0	0	6.752706650627256	66.88508069555189	EGR1;CHRNA3;JUN;CDKN1A;ABLIM1;IGFBP3;SERPINE1;HSPA1B
FSH regulation of apoptosis	8/263	5.2683910033223715E-5	0.0010791879451243283	0	0	6.699062233589088	65.99380496712891	CX3CR1;ABLIM1;IGFBP3;APOE;MAPK14;THBS1;LDLR;GBP1
Fibrinolysis pathway	3/15	5.2826809188518965E-5	0.0010791879451243283	0	0	51.25773195876289	504.8113501315131	SERPINB2;PLAU;SERPINE1
Antigen processing and presentation	5/81	5.3576706495534035E-5	0.0010791879451243283	0	0	13.728531855955678	135.0118210305148	IFNG;KIR2DL1;KIR2DL3;KIR2DL4;HSPA1B
Interleukin-4 regulation of apoptosis	8/267	5.857743558407424E-5	0.0011392301265316506	0	0	6.5942588551284205	64.26211417819931	SLC22A4;JUN;CDKN1A;CXCL8;LRRN3;IFI16;NKG7;UBE2L6
Chylomicron-mediated lipid transport	3/17	7.837829876798801E-5	0.0014735120168381747	0	0	43.930780559646536	415.3199946350019	APOE;LDLRAP1;LDLR
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	8/280	8.165718166311503E-5	0.001485633885741835	0	0	6.274936061381074	59.06585257748565	EGR1;GBP7;IFNG;UBE2L6;FLNB;FCGR1A;JAK3;GBP1
Interleukin-5 regulation of apoptosis	6/144	8.580293270186533E-5	0.0015122766888703764	0	0	9.140610545790935	85.58771719390064	EGR1;CXCL8;CCL3;MAPK14;BIRC3;HBEGF
Regulation of NFAT transcription factors	4/47	8.897220675498297E-5	0.0015206158972669815	0	0	19.24127906976744	179.46699877969036	EGR1;JUN;CXCL8;IFNG
TSH regulation of gene expression	5/97	1.2652505731123543E-4	0.0020243535646470457	0	0	11.331807780320366	101.70377018417237	EGR1;JUN;DUSP2;CXCL8;LRRN3
4-1BB-dependent immune response	3/20	1.2997496316054035E-4	0.0020243535646470457	0	0	36.1728320194057	323.6806038860264	JUN;IFNG;MAPK14
Vitamin B12 metabolism	4/52	1.324843517277032E-4	0.0020243535646470457	0	0	17.23263888888889	153.8710256794273	IFNG;SERPINE1;APOE;LDLR
Wnt signaling pathway and pluripotency	5/98	1.328033366878381E-4	0.0020243535646470457	0	0	11.209394453876627	100.06224230943795	JUN;PLAU;PPP2R2B;PRKCZ;LDLR
Pyrimidine metabolism	5/100	1.460736125883001E-4	0.0021680399342052965	0	0	10.97229916897507	96.9007614271628	NT5E;PNP;POLR1D;CMPK2;DCK
Wnt signaling pathway	7/231	1.611838730962225E-4	0.0023264680974314257	0	0	6.611559139784946	57.73851308035646	JUN;PLAU;PPP2R2B;SIAH1;KREMEN1;PRKCZ;LDLR
TAp63 pathway	4/55	1.649977374064841E-4	0.0023264680974314257	0	0	16.216503267973856	141.2389130217239	CDKN1A;CDKN2A;IGFBP3;MFGE8
Blood clotting cascade	3/23	1.9973029138903675E-4	0.002619718240544575	0	0	30.742268041237114	261.8793213001886	SERPINB2;PLAU;SERPINE1
Signaling events mediated by PRL	3/23	1.9973029138903675E-4	0.002619718240544575	0	0	30.742268041237114	261.8793213001886	EGR1;CDKN1A;RHOC
Cyclins and cell cycle regulation	3/23	1.9973029138903675E-4	0.002619718240544575	0	0	30.742268041237114	261.8793213001886	CDKN1A;CDKN2B;CDKN2A
RAGE pathway	4/60	2.3144518216262018E-4	0.002966706425902677	0	0	14.764880952380953	123.59929166727188	CXCL8;SERPINE1;MFGE8;LDLR
Epidermal growth factor receptor (EGFR) pathway	5/111	2.3812880675793866E-4	0.0029845477113661645	0	0	9.828202581926515	81.99373414021885	JUN;CDKN2A;RHOC;MAPK14;PRKCZ
Folate metabolism	4/63	2.79497344115111E-4	0.0034268804800200565	0	0	14.012005649717514	114.65348518972715	IFNG;SERPINE1;FOLR3;LDLR
TWEAK regulation of gene expression	3/27	3.251243529193447E-4	0.003780655462506138	0	0	25.61340206185567	205.70898832313847	CXCL8;SERPINE1;CCL3
Retinoblastoma protein regulation	4/66	3.3432311010974254E-4	0.003780655462506138	0	0	13.331989247311828	106.70127789939	CDKN1A;JUN;CDKN2A;MAPK14
Signaling by TGF-beta receptor complex	4/66	3.3432311010974254E-4	0.003780655462506138	0	0	13.331989247311828	106.70127789939	CDKN2B;SERPINE1;FURIN;PRKCZ
TGF-beta signaling pathway	6/185	3.3516449135692714E-4	0.003780655462506138	0	0	7.032330916438845	56.264899971539016	TGFBR3;JUN;IFNG;SERPINE1;MAPK14;THBS1
Cell cycle: G1/S checkpoint	3/28	3.6282137198050867E-4	0.003923654402852464	0	0	24.587628865979383	194.773359177925	CDKN1A;CDKN2B;CDKN2A
Cytokine-cytokine receptor interaction	7/265	3.7162002788421867E-4	0.003923654402852464	0	0	5.730349253980162	45.25622778133332	CX3CR1;CXCL8;IFNG;FLT3;CCL3L3;IL24;CCL3
Epithelial cell signaling in Helicobacter pylori infection	4/68	3.7489829307749893E-4	0.003923654402852464	0	0	12.9140625	101.87717668990722	JUN;CXCL8;MAPK14;HBEGF
Chemokine signaling pathway	6/189	3.756690385709805E-4	0.003923654402852464	0	0	6.877223578653645	54.23930080358255	CX3CR1;CXCL8;CCL3L3;CCL3;PRKCZ;JAK3
Lipoprotein metabolism	3/29	4.032210189685461E-4	0.00413484826724109	0	0	23.640761300555116	184.7767981808264	APOE;LDLRAP1;LDLR
Interleukin-1 signaling pathway	5/125	4.1241552456101665E-4	0.004153613497364525	0	0	8.675438596491228	67.61184992387277	JUN;CXCL8;UBE2L6;MAPK14;PRKCZ
Leishmaniasis	4/72	4.6642383261609493E-4	0.004615141080622413	0	0	12.151960784313726	93.21059230650977	JUN;IFNG;FCGR1A;MAPK14
Endocytosis	6/201	5.205446373892402E-4	0.005061847853233301	0	0	6.4500818330605565	48.76671391108642	ARAP2;FOLR3;LDLRAP1;PRKCZ;LDLR;HSPA1B
Interleukin-7 interactions in immune response	3/34	6.484839479590657E-4	0.006199066892354458	0	0	19.822746923844363	145.51627376631131	JUN;CXCL8;IL24
p53 signaling pathway	5/139	6.692051180227493E-4	0.0062905281094138435	0	0	7.763550667714061	56.7470520628467	JUN;CDKN1A;IGFBP3;SERPINE1;HSPA1B
EGF/EGFR signaling pathway	5/141	7.138788699840719E-4	0.00660045381427896	0	0	7.648606811145511	55.41260566743268	ATXN2;JUN;MYBL2;MAPK14;PRKCZ
Toll-like receptor signaling pathway regulation	5/142	7.370346891140768E-4	0.006704638139682893	0	0	7.592393392239724	54.762989036023214	JUN;CXCL8;CCL3;TLR5;MAPK14
ATM-dependent DNA damage response	4/82	7.633074945828872E-4	0.006726647296011693	0	0	10.588675213675213	76.00391815281573	CDKN1A;JUN;PLAU;LDLR
SMAD2/3 nuclear pathway	4/82	7.633074945828872E-4	0.006726647296011693	0	0	10.588675213675213	76.00391815281573	CDKN1A;JUN;CDKN2B;SERPINE1
MAP kinase pathway regulation through dual specificity phosphatases	2/9	8.70867194754317E-4	0.007465267727579203	0	0	57.99708454810496	408.64867956136595	DUSP2;MAPK14
NOD signaling pathway	4/85	8.735951596103323E-4	0.007465267727579203	0	0	10.194958847736626	71.80200933754972	CXCL8;AIM2;MAPK14;BIRC3
Cyclin D-associated events in G1	3/38	9.010656627178086E-4	0.007585090056311106	0	0	17.55375552282769	123.08574753825549	CDKN1A;CDKN2B;CDKN2A
Activation of the AP-1 family of transcription factors	2/10	0.0010850384206118583	0.008869009698914321	0	0	50.744897959183675	346.39177176286466	JUN;MAPK14
Purine catabolism	2/10	0.0010850384206118583	0.008869009698914321	0	0	50.744897959183675	346.39177176286466	NT5E;PNP
Graft-versus-host disease	3/41	0.0011263274602029934	0.009074981250778404	0	0	16.16549104720564	109.74417204757295	IFNG;KIR2DL1;KIR2DL3
Netrin-1 signaling	3/42	0.001208590604538961	0.009600635224788366	0	0	15.750198255352895	105.81456304852415	ABLIM1;SIAH2;SIAH1
Interferon-gamma signaling pathway	4/97	0.0014281711993084983	0.011187341061249903	0	0	8.87410394265233	58.137454351425724	GBP7;IFNG;FCGR1A;GBP1
Interleukin-12/STAT4 pathway	3/45	0.001477785092690149	0.011417408113386904	0	0	14.622974963181148	95.30101139877681	JUN;IFNG;MAPK14
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	3/47	0.0016765192380744738	0.012777795273973018	0	0	13.95688847235239	89.19896993336747	AIM2;MAPK14;BIRC3
Lipid digestion, mobilization, and transport	3/48	0.0017818416942912629	0.013399449541070295	0	0	13.646048109965635	86.3809554416349	APOE;LDLRAP1;LDLR
Purine salvage	2/13	0.0018624280503563755	0.013821176584223629	0	0	36.89981447124304	231.94759321375395	PNP;DCK
TGF-beta regulation of extracellular matrix	9/565	0.002093529802809754	0.015334426088113003	0	0	3.4409044193216856	21.22660813008021	CLK1;TGFBR3;SELENBP1;CDKN2B;MME;CDKN2A;SERPINE1;SLC2A1;APOE
Malaria	3/51	0.0021222963043568428	0.01534583481611871	0	0	12.791237113402062	78.73334684431502	CXCL8;IFNG;THBS1
Platelet amyloid precursor protein pathway	2/14	0.0021657651600423137	0.015461918357770442	0	0	33.82312925170068	207.5042741698455	PLAU;SERPINE1
Androgen receptor regulation of biosynthesis and transcription	3/53	0.0023702048008991446	0.01670994384633897	0	0	12.278350515463918	74.219914290735	EGR1;JUN;MAPK14
Adhesion and diapedesis of granulocytes	2/15	0.0024908343052083164	0.016991993706460918	0	0	31.21978021978022	187.16687708215863	CXCL8;IFNG
Erythrocyte differentiation pathway	2/15	0.0024908343052083164	0.016991993706460918	0	0	31.21978021978022	187.16687708215863	FLT3;CCL3
Binding of chemokines to chemokine receptors	3/54	0.0025005948185040003	0.016991993706460918	0	0	12.036992116434202	72.11634792982616	CX3CR1;CXCL8;CCL3
Fas signaling pathway	4/115	0.002661302293846886	0.01783817567993606	0	0	7.428303303303303	44.04196229800182	CXCL8;MAPK14;PRKCZ;BIRC3
Insulin signaling pathway	6/277	0.0026883775404158952	0.01783817567993606	0	0	4.6233021904687135	27.364481506624642	EGR1;JUN;SLC2A1;RHOC;MAPK14;PRKCZ
Thromboxane A2 receptor signaling	3/56	0.0027744926921681934	0.0181955102137542	0	0	11.581598910717759	68.1842009003188	MAPK14;PRKCZ;TGM2
Selenium metabolism and selenoproteins	2/16	0.0028374149918175937	0.01839427649867957	0	0	28.988338192419825	170.01259891772904	SELENBP1;JUN
Keratinocyte differentiation	3/57	0.002918095947541711	0.01850830113552902	0	0	11.36655211912944	66.3445636168701	JUN;MAPK14;BIRC3
Prolactin regulation of apoptosis	4/118	0.0029206361720958912	0.01850830113552902	0	0	7.231725146198831	42.204013986909175	LDHB;EGR1;GBP1;BACH2
Selenium pathway	3/60	0.003376073956019611	0.021156730124389563	0	0	10.766684753119913	61.27365293527066	IFNG;SERPINE1;LDLR
p75 neurotrophin receptor-mediated signaling	4/124	0.0034901927235166455	0.021631524132564705	0	0	6.868055555555555	38.85807320211981	FURIN;RHOC;PRKCZ;BIRC3
FGF signaling pathway	3/61	0.003537936569638058	0.02168908940517244	0	0	10.580519018841095	59.718688304120505	JUN;PLAU;MAPK14
Pertussis toxin-insensitive CCR5 signaling in macrophage	2/18	0.0035942371173740815	0.021797308969881527	0	0	25.362244897959183	142.74945562505079	JUN;MAPK14
Shigellosis	3/62	0.0037044719565665243	0.022226831739399145	0	0	10.400663987419186	58.22514848728369	CXCL8;WASF1;MAPK14
TP53 network	2/19	0.004004045638803338	0.02352376812796961	0	0	23.869147659063625	131.7684366549516	CDKN1A;CDKN2A
Tob role in T-cell activation	2/19	0.004004045638803338	0.02352376812796961	0	0	23.869147659063625	131.7684366549516	TGFBR3;IFNG
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	3/64	0.004051724989556021	0.02355848344442882	0	0	10.058644583403751	55.40917594097984	EGR1;MAPK14;PRKCZ
Interleukin-12-mediated signaling events	3/65	0.00423252222637027	0.024112550865382144	0	0	9.895909544396408	54.0807220421003	IFNG;CCL3;MAPK14
LPA receptor mediated events	3/65	0.00423252222637027	0.024112550865382144	0	0	9.895909544396408	54.0807220421003	JUN;CXCL8;HBEGF
Beta-1 integrin cell surface interactions	3/66	0.004418151436739624	0.02452017562755228	0	0	9.738340697103583	52.80161336369526	PLAU;THBS1;TGM2
Estrogen receptor signaling pathway	2/20	0.004434499847536051	0.02452017562755228	0	0	22.541950113378686	122.13995997533476	JUN;MAPK14
Hypertrophy pathway	2/20	0.004434499847536051	0.02452017562755228	0	0	22.541950113378686	122.13995997533476	IFNG;HBEGF
G1 to S cell cycle control	3/67	0.004608650082634319	0.025235715015589865	0	0	9.58569587628866	51.56932115539997	CDKN1A;CDKN2B;CDKN2A
Mitotic G1-G1/S phases	4/135	0.00472233374393165	0.025609579149783183	0	0	6.287849872773537	33.674279209969015	CDKN1A;CDKN2B;CDKN2A;MYBL2
CD8/T cell receptor downstream pathway	3/68	0.004804054710309247	0.025804636729661094	0	0	9.437747819191118	50.38148186551567	EGR1;JUN;IFNG
Oxidative stress-induced gene expression via Nrf2	2/21	0.00488538725831669	0.025975314972417084	0	0	21.354457572502685	113.63788950907963	JUN;MAPK14
MAPK signaling pathway	6/314	0.004955742792688869	0.025975314972417084	0	0	4.06023763470572	21.54852652865833	JUN;DUSP2;FLNB;MAPK14;PRKCZ;HSPA1B
Natural killer cell-mediated cytotoxicity	4/137	0.004973996484079867	0.025975314972417084	0	0	6.192669172932331	32.84301689755327	IFNG;KIR2DL1;KIR2DL3;KIR2DL4
Developmental biology	7/420	0.005144498064819063	0.026352688150191695	0	0	3.5514853289593584	18.715714954068368	ABLIM1;SIAH2;SIAH1;FURIN;ANGPTL4;RHOC;MAPK14
CDC42 signaling events	3/70	0.00520972357949959	0.026352688150191695	0	0	9.155100784736113	48.13045658628783	JUN;MAPK14;PRKCZ
Nucleotide metabolism	3/70	0.00520972357949959	0.026352688150191695	0	0	9.155100784736113	48.13045658628783	NT5E;PNP;DCK
T cell receptor signaling pathway	4/139	0.005234517220934926	0.026352688150191695	0	0	6.1003086419753085	32.04175316395329	JUN;IFNG;ARAP2;MAPK14
Innate immune system	6/319	0.005345434471760531	0.026352688150191695	0	0	3.994357963428727	20.896533424085295	JUN;AIM2;UBE2L6;TLR5;MAPK14;BIRC3
Rac1 cell motility signaling pathway	3/71	0.005420056428053611	0.026352688150191695	0	0	9.020012128562765	47.06325773617709	JUN;WASF1;MAPK14
Interleukin-6 signaling pathway	3/71	0.005420056428053611	0.026352688150191695	0	0	9.020012128562765	47.06325773617709	JUN;MAPK14;JAK3
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	3/71	0.005420056428053611	0.026352688150191695	0	0	9.020012128562765	47.06325773617709	DAPK2;PRKCZ;HSPA1B
Hypoxia and p53 in the cardiovascular system	2/23	0.005847619592062275	0.028188525213018144	0	0	19.318756073858115	99.33164622370634	CDKN1A;IGFBP3
RANKL regulation of apoptosis and immune response	3/74	0.006081441880416014	0.02906723068266637	0	0	8.637578045593147	44.073358237157414	EGR1;JUN;CCL3
Tumor suppressor Arf inhibits ribosomal biogenesis	2/24	0.006358547360763446	0.0298851725955882	0	0	18.43970315398887	93.26719485343038	CDKN2A;POLR1D
Nicotinate and nicotinamide metabolism	2/24	0.006358547360763446	0.0298851725955882	0	0	18.43970315398887	93.26719485343038	NT5E;PNP
IGF1 receptor signaling through beta-arrestin	2/25	0.006889074002829973	0.03211105568261243	0	0	17.637089618456077	87.79423275712823	PPP2R2B;MAPK14
Apoptosis regulation	3/78	0.007035335639566523	0.03252401066160262	0	0	8.175257731958762	40.523198294001766	CDKN1A;IFNG;DAPK2
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	3/79	0.007286866254448595	0.03314348844765329	0	0	8.067281606077048	39.704592204651284	EGR1;JUN;PRKCZ
p73 transcription factor network	3/79	0.007286866254448595	0.03314348844765329	0	0	8.067281606077048	39.704592204651284	CDKN1A;SERPINE1;MAPK14
Physiological and pathological hypertrophy  of the heart	2/26	0.0074389947886241	0.03323931175549067	0	0	16.901360544217688	82.83389842043363	JUN;MAPK14
Selective expression of chemokine receptors during T-cell polarization	2/26	0.0074389947886241	0.03323931175549067	0	0	16.901360544217688	82.83389842043363	IFNG;CCL3
Apoptosis modulation and signaling	3/80	0.007543673589898592	0.03323931175549067	0	0	7.96211005489356	38.91119811203056	JUN;CDKN2A;BIRC3
Nuclear beta-catenin signaling and target gene transcription regulation	3/80	0.007543673589898592	0.03323931175549067	0	0	7.96211005489356	38.91119811203056	JUN;CXCL8;CDKN2A
Integrin signaling pathway	4/155	0.007653705691676589	0.033462713256632526	0	0	5.449503311258278	26.553060978024	JUN;CDKN2A;RHOC;MAPK14
CTCF pathway	2/27	0.008008106510589556	0.0344776494043703	0	0	16.224489795918366	78.32049478663112	TGFBR3;CDKN2A
TNF/stress-related signaling	2/27	0.008008106510589556	0.0344776494043703	0	0	16.224489795918366	78.32049478663112	JUN;MAPK14
Toll receptor cascades	4/159	0.00835627404208797	0.035704079998012235	0	0	5.307795698924731	25.396436404946193	JUN;UBE2L6;TLR5;MAPK14
Differentiation pathway in PC12 cells	3/84	0.008624169104403879	0.03657166447281043	0	0	7.567392134402444	35.9692273171892	EGR1;JUN;MAPK14
C-Myb transcription factor network	3/85	0.008907727513708056	0.03721450605726921	0	0	7.474729695750566	35.28697392743489	CDKN1A;CDKN2A;BIRC3
TGF-beta regulation of skeletal system development	3/85	0.008907727513708056	0.03721450605726921	0	0	7.474729695750566	35.28697392743489	CDKN2B;IFNG;THBS1
Hemostasis pathway	7/468	0.009095842288746683	0.037612659246119555	0	0	3.173862337601754	14.91695576677091	SERPINB2;PLAU;SIRPG;SERPINE1;MAPK14;PRKCZ;THBS1
Statin pathway	2/29	0.009203097475114358	0.037612659246119555	0	0	15.02116402116402	70.4224490277819	APOE;LDLR
T cell receptor calcium pathway	2/29	0.009203097475114358	0.037612659246119555	0	0	15.02116402116402	70.4224490277819	JUN;IFNG
Purine metabolism	4/164	0.009292325071729024	0.03770411036298683	0	0	5.140625	24.0507558145541	NT5E;PNP;POLR1D;DCK
Hematopoietic cell lineage	3/88	0.009790996030666814	0.03849526313111474	0	0	7.209824135839903	33.35475235562723	MME;FLT3;FCGR1A
TNFR1 signaling pathway	2/30	0.009828577820710147	0.03849526313111474	0	0	14.48396501457726	66.95156387938638	JUN;BIRC3
Tumor necrosis factor (TNF) pathway	2/30	0.009828577820710147	0.03849526313111474	0	0	14.48396501457726	66.95156387938638	JUN;BIRC3
Inflammatory response pathway	2/30	0.009828577820710147	0.03849526313111474	0	0	14.48396501457726	66.95156387938638	IFNG;THBS1
Nuclear events mediated by MAP kinases	2/30	0.009828577820710147	0.03849526313111474	0	0	14.48396501457726	66.95156387938638	JUN;MAPK14
Alpha-V beta-3 integrin/OPN pathway	2/31	0.010472451285062238	0.04045522277243221	0	0	13.983814215341308	63.75230908786907	JUN;PLAU
NF-kappaB activation by non-typeable Hemophilus influenzae	2/31	0.010472451285062238	0.04045522277243221	0	0	13.983814215341308	63.75230908786907	CXCL8;MAPK14
ERBB signaling pathway	3/94	0.011705944528026261	0.04491260349528443	0	0	6.732411917978928	29.943469004228515	CDKN1A;JUN;HBEGF
HIF-2-alpha transcription factor network	2/34	0.012512480224535567	0.047362676823074226	0	0	12.670918367346939	55.51165721021778	SERPINE1;SLC2A1
MAPK/TRK pathway	2/34	0.012512480224535567	0.047362676823074226	0	0	12.670918367346939	55.51165721021778	EGR1;MAPK14
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	3/97	0.012738546663725812	0.04789693545560905	0	0	6.516560649265189	28.432553772777887	JUN;PPP2R2B;PRKCZ
Autophagy regulation	2/35	0.013227983272248344	0.04876197755260173	0	0	12.286332714904143	53.14355844722063	IFNG;GABARAP
Cytokines and inflammatory response	2/35	0.013227983272248344	0.04876197755260173	0	0	12.286332714904143	53.14355844722063	CXCL8;IFNG
Interleukin-2/PI3K pathway	2/35	0.013227983272248344	0.04876197755260173	0	0	12.286332714904143	53.14355844722063	PRKCZ;JAK3
TNF-alpha signaling pathway	3/101	0.014194132732163073	0.0516483281350966	0	0	6.249316221333895	26.590381744700988	JUN;PRKCZ;BIRC3
GnRH signaling pathway	3/101	0.014194132732163073	0.0516483281350966	0	0	6.249316221333895	26.590381744700988	JUN;MAPK14;HBEGF
Interleukin-23-mediated signaling events	2/37	0.014711087587821891	0.05318623974058684	0	0	11.583090379008746	48.87083992538764	IFNG;IL24
Signal transduction through IL-1R	2/38	0.015478313223536513	0.05525170036756071	0	0	11.260770975056689	46.9384448645158	JUN;MAPK14
p38 alpha/beta MAPK downstream pathway	2/38	0.015478313223536513	0.05525170036756071	0	0	11.260770975056689	46.9384448645158	JUN;MAPK14
Amoebiasis	3/105	0.01574044098751093	0.05548505448097602	0	0	6.003032140691328	24.921720115184357	CXCL8;SERPINB2;IFNG
Fibroblast growth factor receptor pathway	3/105	0.01574044098751093	0.05548505448097602	0	0	6.003032140691328	24.921720115184357	CDKN2A;MAPK14;PRKCZ
ERBB1 downstream pathway	3/106	0.016141267057155385	0.05654456285860644	0	0	5.944450005004504	24.52903651782376	EGR1;JUN;PRKCZ
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling	2/39	0.016262406432153827	0.05661726683786888	0	0	10.955874241588527	45.126141525786544	JUN;MAPK14
G alpha i pathway	3/108	0.016960075344073944	0.05868394168133561	0	0	5.830633284241531	23.77086922419914	MAPK14;PRKCZ;HBEGF
Jak-STAT signaling pathway	4/199	0.017778331562796207	0.06038670238284783	0	0	4.210470085470085	16.967246630417783	CXCL8;IFNG;IL24;JAK3
Alpha-M beta-2 integrin signaling	2/41	0.017880459748112743	0.06038670238284783	0	0	10.392987964416536	41.82186992516352	PLAU;PRKCZ
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer	2/41	0.017880459748112743	0.06038670238284783	0	0	10.392987964416536	41.82186992516352	CDKN2B;SERPINE1
FOXM1 transcription factor network	2/41	0.017880459748112743	0.06038670238284783	0	0	10.392987964416536	41.82186992516352	CDKN2A;HSPA1B
TWEAK signaling pathway	2/42	0.01871405540009226	0.062454007370722105	0	0	10.13265306122449	40.31256172341721	JUN;MAPK14
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	2/42	0.01871405540009226	0.062454007370722105	0	0	10.13265306122449	40.31256172341721	PLAU;SERPINE1
Beta-3 integrin cell surface interactions	2/43	0.01956378970919087	0.06462597286659513	0	0	9.885017421602788	38.888398778373954	PLAU;THBS1
Platelet activation, signaling and aggregation	4/205	0.019594044964871927	0.06462597286659513	0	0	4.083540630182421	16.05864434886333	SERPINE1;MAPK14;PRKCZ;THBS1
PI3K events in ERBB2 signaling	2/44	0.020429483861515323	0.0669897028947363	0	0	9.649173955296405	37.54277574025534	CDKN1A;HBEGF
RhoA signaling pathway	2/45	0.02131096041448218	0.06868218099295971	0	0	9.424299952539155	36.26973658038426	JUN;PRKCZ
Wnt interactions in lipid metabolism and immune response	2/45	0.02131096041448218	0.06868218099295971	0	0	9.424299952539155	36.26973658038426	SIAH2;APOE
Interleukin-3 signaling pathway	2/45	0.02131096041448218	0.06868218099295971	0	0	9.424299952539155	36.26973658038426	JUN;CXCL8
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	3/119	0.021874299104735526	0.07009718576744793	0	0	5.274795591894774	20.16260489683167	KIR2DL1;KIR2DL3;KIR2DL4
Notch signaling pathway	3/121	0.02284271060386328	0.07278694226315757	0	0	5.18486807618382	19.594255356497303	CDKN1A;FURIN;BIRC3
Delta Np63 pathway	2/47	0.02312055761715071	0.07325839604535393	0	0	9.004535147392291	33.92038210413699	CDKN2A;IGFBP3
Signaling by PDGF	3/122	0.023335570915909605	0.07352660333281015	0	0	5.141037858442346	19.318870909741264	CDKN1A;FURIN;THBS1
ATM pathway	2/48	0.024048330053217173	0.07535143416674714	0	0	8.808340727595386	32.83476119194659	CDKN1A;JUN
Phospholipase C delta-1 interactions in phospholipid-associated cell signaling	1/5	0.024753528718293626	0.07577973266848301	0	0	50.24242424242424	185.83603697375267	TGM2
Kit receptor transcriptional targets	1/5	0.024753528718293626	0.07577973266848301	0	0	50.24242424242424	185.83603697375267	SLC2A1
Maturation of Notch precursor via proteolytic cleavage	1/5	0.024753528718293626	0.07577973266848301	0	0	50.24242424242424	185.83603697375267	FURIN
Angiopoietin receptor Tie2-mediated signaling	2/49	0.024991188433223118	0.07577973266848301	0	0	8.620495006513243	31.803005852102093	CDKN1A;MAPK14
Ceramide signaling pathway	2/49	0.024991188433223118	0.07577973266848301	0	0	8.620495006513243	31.803005852102093	PRKCZ;BIRC3
G alpha 12 pathway	2/49	0.024991188433223118	0.07577973266848301	0	0	8.620495006513243	31.803005852102093	JUN;MAPK14
Type II interferon signaling (interferon-gamma)	2/50	0.025948961945953097	0.07826317934501362	0	0	8.44047619047619	30.82144266223132	IFNG;GBP1
PI3K pathway	2/53	0.028910084539220875	0.08673025361766262	0	0	7.942777110844338	28.145745374205482	CDKN2A;PRKCZ
Focal adhesion	4/233	0.029557234253209632	0.0870409549710847	0	0	3.5791484716157207	12.603709174137336	JUN;FLNB;THBS1;BIRC3
ADP signalling through P2Y purinoceptor 1	1/6	0.029630963394411815	0.0870409549710847	0	0	40.19191919191919	141.432767389918	MAPK14
Proteolysis and signaling pathway of Notch	1/6	0.029630963394411815	0.0870409549710847	0	0	40.19191919191919	141.432767389918	FURIN
Low-density lipoprotein (LDL) pathway during atherogenesis	1/6	0.029630963394411815	0.0870409549710847	0	0	40.19191919191919	141.432767389918	LDLR
RANKL signaling pathway	2/54	0.02992583628203801	0.08745166664802817	0	0	7.789638932496075	27.334100710931292	JUN;MAPK14
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	3/135	0.03026696369023689	0.0879926160891423	0	0	4.631677600749765	16.200211650899902	CXCL8;BIRC3;HBEGF
Ubiquitin-mediated proteolysis	3/136	0.030840345798215468	0.0890765152077322	0	0	4.596620417021937	15.991327643666999	SIAH1;UBE2L6;BIRC3
Calcineurin-dependent NFAT signaling role in lymphocytes	2/55	0.03095566840552396	0.0890765152077322	0	0	7.642279553330766	26.55844340345009	MAPK14;PRKCZ
Signal transduction	10/1020	0.031316560870637916	0.08965756513218165	0	0	2.078107810781078	7.1977512955972855	CX3CR1;JUN;CDKN1A;CDKN2B;CXCL8;ARAP2;CCL3;FURIN;MAPK14;HBEGF
Cytosolic DNA-sensing pathway	2/56	0.03199941777272016	0.09114985668593016	0	0	7.500377928949358	25.81658262777106	AIM2;POLR1D
Pre-NOTCH expression and processing	2/57	0.03305692249429009	0.09322052143389804	0	0	7.363636363636363	25.106496966632545	JUN;FURIN
SHP2 signaling	2/57	0.03305692249429009	0.09322052143389804	0	0	7.363636363636363	25.106496966632545	IFNG;JAK3
Apoptosis	4/242	0.03329421117702152	0.09342256270567233	0	0	3.4422268907563027	11.711735480752989	JUN;CDKN2A;DAPK2;BIRC3
Arachidonate epoxygenase/epoxide hydrolase pathway	1/7	0.03448424920041465	0.09487373926357981	0	0	33.49158249158249	112.77461836050252	EPHX2
SARS coronavirus protease	1/7	0.03448424920041465	0.09487373926357981	0	0	33.49158249158249	112.77461836050252	MAPK14
FXR and LXR regulation of cholesterol metabolism	1/7	0.03448424920041465	0.09487373926357981	0	0	33.49158249158249	112.77461836050252	LDLR
Highly sodium permeable acetylcholine nicotinic receptors	1/7	0.03448424920041465	0.09487373926357981	0	0	33.49158249158249	112.77461836050252	CHRNA3
Proepithelin conversion to epithelin and wound repair control	1/8	0.03931350415205654	0.10609003034334874	0	0	28.705627705627705	92.89678500716381	CXCL8
SREBP control of lipid biosynthesis	1/8	0.03931350415205654	0.10609003034334874	0	0	28.705627705627705	92.89678500716381	LDLR
Vitamin C (ascorbate) metabolism	1/8	0.03931350415205654	0.10609003034334874	0	0	28.705627705627705	92.89678500716381	SLC2A1
Organic cation transport	1/8	0.03931350415205654	0.10609003034334874	0	0	28.705627705627705	92.89678500716381	SLC22A4
Endothelins	2/64	0.040831265524650134	0.10966111312334606	0	0	6.529953917050691	20.88479849248963	JUN;MAPK14
Glioma	2/65	0.04199313241076799	0.11224704587522819	0	0	6.425979915775834	20.371957610722255	CDKN1A;CDKN2A
Myometrial relaxation and contraction pathways	3/155	0.04281109238449092	0.11389366087194755	0	0	4.018176885512751	12.661106772029475	JUN;IGFBP3;PRKCZ
Thyroid-stimulating hormone signaling pathway	2/66	0.04316735256679497	0.11430228566982331	0	0	6.325255102040816	19.87819449312978	JUN;MAPK14
Pyrimidine salvage reactions	1/9	0.0441188457824273	0.1151992084318935	0	0	25.116161616161616	78.3842312444799	DCK
Rapid glucocorticoid receptor pathway	1/9	0.0441188457824273	0.1151992084318935	0	0	25.116161616161616	78.3842312444799	MAPK14
EGFR transactivation by gastrin	1/9	0.0441188457824273	0.1151992084318935	0	0	25.116161616161616	78.3842312444799	HBEGF
Telomerase regulation	2/67	0.04435377617601188	0.11527893900124747	0	0	6.227629513343799	19.402537395096388	JUN;IFNG
NFAT involvement in hypertrophy of the heart	2/69	0.04676264021877073	0.12098224350177382	0	0	6.041120925982333	18.501963939065423	MAPK14;HBEGF
Antiviral mechanism by interferon-stimulated genes	2/70	0.04798478677458479	0.12245891285459647	0	0	5.951980792316927	18.075399411278084	UBE2L6;FLNB
Renal cell carcinoma	2/70	0.04798478677458479	0.12245891285459647	0	0	5.951980792316927	18.075399411278084	JUN;SLC2A1
Complement and coagulation cascades	2/70	0.04798478677458479	0.12245891285459647	0	0	5.951980792316927	18.075399411278084	PLAU;SERPINE1
DCC role in regulating apoptosis	1/10	0.04890039114183046	0.12337449619449053	0	0	22.32435465768799	67.37423003045056	DAPK2
Free radical-induced apoptosis	1/10	0.04890039114183046	0.12337449619449053	0	0	22.32435465768799	67.37423003045056	CXCL8
RIG-I-like receptor signaling pathway	2/71	0.04921854901375952	0.12337449619449053	0	0	5.865424430641822	17.663636014354466	CXCL8;MAPK14
Melanoma	2/71	0.04921854901375952	0.12337449619449053	0	0	5.865424430641822	17.663636014354466	CDKN1A;CDKN2A
Chronic myeloid leukemia	2/73	0.05172034528607497	0.1285034129574726	0	0	5.699626329405001	16.881746303056282	CDKN1A;CDKN2A
Myc repressed pathway	2/73	0.05172034528607497	0.1285034129574726	0	0	5.699626329405001	16.881746303056282	CDKN1A;CDKN2B
Seven transmembrane receptor signaling through beta-arrestin	2/74	0.05298809449300122	0.12933015729695385	0	0	5.620181405895692	16.510339602462818	PPP2R2B;MAPK14
Down syndrome cell adhesion molecule (DSCAM) interactions	1/11	0.05365825675086383	0.12933015729695385	0	0	20.09090909090909	58.768318421882675	MAPK14
Erythropoietin-mediated neuroprotection through NF-kB	1/11	0.05365825675086383	0.12933015729695385	0	0	20.09090909090909	58.768318421882675	CDKN1A
Vitamin C in the brain	1/11	0.05365825675086383	0.12933015729695385	0	0	20.09090909090909	58.768318421882675	SLC2A1
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	1/11	0.05365825675086383	0.12933015729695385	0	0	20.09090909090909	58.768318421882675	FURIN
Glypican-3 pathway	1/11	0.05365825675086383	0.12933015729695385	0	0	20.09090909090909	58.768318421882675	FURIN
Osteopontin signaling	1/11	0.05365825675086383	0.12933015729695385	0	0	20.09090909090909	58.768318421882675	PLAU
Prolactin activation of MAPK signaling	2/75	0.05426688973122658	0.12968866867971096	0	0	5.542913055633212	16.15116734069409	JUN;MAPK14
Glycolysis and gluconeogenesis	2/75	0.05426688973122658	0.12968866867971096	0	0	5.542913055633212	16.15116734069409	LDHB;SLC2A1
Mitochondrial pathway of apoptosis: caspases	2/77	0.05685706083640968	0.13497296327526492	0	0	5.394557823129252	15.467356382357153	HSPA1B;BIRC3
Parkin role in the ubiquitin-proteasomal pathway	1/12	0.05839255858007915	0.13497296327526492	0	0	18.26354453627181	51.878818604154176	UBE2L6
Pyrimidine catabolism	1/12	0.05839255858007915	0.13497296327526492	0	0	18.26354453627181	51.878818604154176	NT5E
SODD/TNFR1 signaling pathway	1/12	0.05839255858007915	0.13497296327526492	0	0	18.26354453627181	51.878818604154176	BIRC3
Salmonella infection	1/12	0.05839255858007915	0.13497296327526492	0	0	18.26354453627181	51.878818604154176	WASF1
D4-GDI signaling pathway	1/12	0.05839255858007915	0.13497296327526492	0	0	18.26354453627181	51.878818604154176	JUN
Facilitative sodium-independent glucose transporters	1/12	0.05839255858007915	0.13497296327526492	0	0	18.26354453627181	51.878818604154176	SLC2A1
Gamma-aminobutyric acid receptor life cycle	1/12	0.05839255858007915	0.13497296327526492	0	0	18.26354453627181	51.878818604154176	GABARAP
Metabolism	13/1615	0.058850162004298705	0.13547547498132437	0	0	1.7067315281185873	4.834761985411499	EPHX2;DCK;AGMAT;LDHB;NT5E;PNP;POLR1D;CMPK2;PHGDH;APOE;ANGPTL4;LDLRAP1;LDLR
MAP kinase signaling pathway	2/81	0.06216388427865964	0.1412314461116556	0	0	5.120382330147248	14.224325268693594	JUN;MAPK14
Signal regulatory protein (SIRP) family interactions	1/13	0.06310341209244187	0.1412314461116556	0	0	16.74074074074074	46.254339159717055	SIRPG
TACI and BCMA stimulation of B cell immune responses	1/13	0.06310341209244187	0.1412314461116556	0	0	16.74074074074074	46.254339159717055	MAPK14
Ghrelin-mediated regulation of food intake and energy homeostasis	1/13	0.06310341209244187	0.1412314461116556	0	0	16.74074074074074	46.254339159717055	IGFBP3
Interleukin-22 soluble receptor signaling pathway	1/13	0.06310341209244187	0.1412314461116556	0	0	16.74074074074074	46.254339159717055	JAK3
MAP kinase downregulation by phosphorylation of MEK1 by Cdk5/p35	1/13	0.06310341209244187	0.1412314461116556	0	0	16.74074074074074	46.254339159717055	EGR1
Organic cation/anion/zwitterion transport	1/13	0.06310341209244187	0.1412314461116556	0	0	16.74074074074074	46.254339159717055	SLC22A4
Response to elevated platelet cytosolic calcium	2/83	0.06487838023453162	0.1440606553239206	0	0	4.99344923154447	13.658286245847663	SERPINE1;THBS1
T cell signal transduction	2/83	0.06487838023453162	0.1440606553239206	0	0	4.99344923154447	13.658286245847663	MAPK14;PRKCZ
Small cell lung cancer	2/84	0.06625043590600445	0.14537675187450838	0	0	4.9323046291687405	13.387819731164345	CDKN2B;BIRC3
AKT phosphorylation of cytosolic targets	1/14	0.0677909321684321	0.14537675187450838	0	0	15.452214452214452	41.58695944336839	CDKN1A
Acetylcholine binding and downstream events	1/14	0.0677909321684321	0.14537675187450838	0	0	15.452214452214452	41.58695944336839	CHRNA3
Polyamine metabolism	1/14	0.0677909321684321	0.14537675187450838	0	0	15.452214452214452	41.58695944336839	AGMAT
Adhesion and diapedesis of lymphocytes	1/14	0.0677909321684321	0.14537675187450838	0	0	15.452214452214452	41.58695944336839	CXCL8
T cell receptor/JNK pathway	1/14	0.0677909321684321	0.14537675187450838	0	0	15.452214452214452	41.58695944336839	JUN
DCC-mediated attractive signaling	1/14	0.0677909321684321	0.14537675187450838	0	0	15.452214452214452	41.58695944336839	ABLIM1
Interferon gamma signaling regulation	1/14	0.0677909321684321	0.14537675187450838	0	0	15.452214452214452	41.58695944336839	IFNG
MAP kinase inactivation of SMRT corepressor	1/14	0.0677909321684321	0.14537675187450838	0	0	15.452214452214452	41.58695944336839	MAPK14
Peptide G-protein coupled receptors	3/192	0.0717418991703997	0.15079244100014969	0	0	3.2254950090001637	8.498148268482408	CX3CR1;CXCL8;CCL3
Androgen receptor signaling, proteolysis, and transcription regulation	2/88	0.07183435427290809	0.15079244100014969	0	0	4.701945894636925	12.382068798517093	CDKN1A;JUN
HIF-1 degradation in normoxia	2/88	0.07183435427290809	0.15079244100014969	0	0	4.701945894636925	12.382068798517093	MAPK14;PRKCZ
Repression of pain sensation by the transcriptional regulator DREAM	1/15	0.07245523317560384	0.15079244100014969	0	0	14.347763347763347	37.659813836990104	JUN
Calcium signaling by HBx of hepatitis B virus	1/15	0.07245523317560384	0.15079244100014969	0	0	14.347763347763347	37.659813836990104	JUN
HDL-mediated lipid transport	1/15	0.07245523317560384	0.15079244100014969	0	0	14.347763347763347	37.659813836990104	APOE
Hematopoiesis regulation by cytokines	1/15	0.07245523317560384	0.15079244100014969	0	0	14.347763347763347	37.659813836990104	CXCL8
Interleukin-17 signaling pathway	1/15	0.07245523317560384	0.15079244100014969	0	0	14.347763347763347	37.659813836990104	CXCL8
Thymic stromal lymphopoietin (TSLP) pathway	2/90	0.07468194968548275	0.15485521920078044	0	0	4.594619666048238	11.920818158765337	CXCL8;CCL3
Cell cycle	5/453	0.07694569623303567	0.15529423541733067	0	0	2.2852443609022557	5.860864175460557	CDKN1A;CDKN2B;CDKN2A;MYBL2;NDEL1
Amino acid biosynthesis and interconversion (transamination)	1/16	0.0770964289305897	0.15529423541733067	0	0	13.390572390572391	34.31599732708391	PHGDH
Rb tumor suppressor/checkpoint signaling in response to DNA damage	1/16	0.0770964289305897	0.15529423541733067	0	0	13.390572390572391	34.31599732708391	CDKN1A
SREBF and miR-33 in cholesterol and lipid homeostasis	1/16	0.0770964289305897	0.15529423541733067	0	0	13.390572390572391	34.31599732708391	LDLR
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1/16	0.0770964289305897	0.15529423541733067	0	0	13.390572390572391	34.31599732708391	PRKCZ
Hypoxia-inducible factor in the cardivascular system	1/16	0.0770964289305897	0.15529423541733067	0	0	13.390572390572391	34.31599732708391	JUN
Interleukin-10 anti-inflammatory signaling pathway	1/16	0.0770964289305897	0.15529423541733067	0	0	13.390572390572391	34.31599732708391	MAPK14
Interleukin-9 signaling pathway	1/16	0.0770964289305897	0.15529423541733067	0	0	13.390572390572391	34.31599732708391	JAK3
Signaling by ERBB4	2/93	0.07902008216924429	0.15569950279309933	0	0	4.442475891455484	11.27524039277228	CDKN1A;HBEGF
Axon guidance	4/325	0.08021610955073268	0.15569950279309933	0	0	2.541407061266874	6.412048588422785	ABLIM1;SIAH2;SIAH1;RHOC
Fc gamma receptor-mediated phagocytosis	2/94	0.08048343457235077	0.15569950279309933	0	0	4.39396628216504	11.071493966406615	WASF1;FCGR1A
Platelet sensitization by LDL	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	MAPK14
Renin-angiotensin system	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	MME
Atypical NF-kappaB pathway	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	MAPK14
Cadmium-induced DNA biosynthesis and proliferation in macrophages	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	JUN
Cells and molecules involved in local acute inflammatory response	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	CXCL8
Syndecan 3 pathway	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	CXCL8
TAK1-mediated activation of p38 MAPK	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	MAPK14
Dendritic cells in regulating TH1 and TH2 development	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	IFNG
Destabilization of mRNA by KSRP	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	MAPK14
Inflammasomes	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	AIM2
Insulin-like growth factor (IGF) activity regulation by insulin-like growth factor binding proteins (IGFBPs)	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	IGFBP3
Integrin beta-5 pathway	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	PLAU
NO2-dependent IL-12 pathway in NK cells	1/17	0.08171463267155567	0.15569950279309933	0	0	12.553030303030303	31.43934295429433	IFNG
Adaptive immune system	6/606	0.0833362669507848	0.1579112562485483	0	0	2.0531914893617023	5.101916907134619	CDKN1A;UBE2L6;KIR2DL1;FCGR1A;KIR2DL3;KIR2DL4
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	2/96	0.08343538007458758	0.1579112562485483	0	0	4.300043421623969	10.679944049183515	SLC22A4;SLC2A1
Pre-NOTCH processing in Golgi	1/18	0.08630995715059277	0.16118813189713352	0	0	11.81402257872846	28.942114306609312	FURIN
Serotonin receptor 4/6/7 and NR3C signaling	1/18	0.08630995715059277	0.16118813189713352	0	0	11.81402257872846	28.942114306609312	EGR1
Effect of METS on macrophage differentiation	1/18	0.08630995715059277	0.16118813189713352	0	0	11.81402257872846	28.942114306609312	JUN
Human cytomegalovirus and MAP kinase pathways	1/18	0.08630995715059277	0.16118813189713352	0	0	11.81402257872846	28.942114306609312	MAPK14
Antigen-activated B-cell receptor generation of second messengers	3/211	0.08925183079658232	0.16534754257550138	0	0	2.928033306899286	7.074987394587304	JUN;MAPK14;PRKCZ
Apoptosis modulation by HSP70	1/19	0.09088251453617983	0.16534754257550138	0	0	11.15712682379349	26.75688382123247	HSPA1B
STAT3 pathway	1/19	0.09088251453617983	0.16534754257550138	0	0	11.15712682379349	26.75688382123247	JAK3
Signaling by NODAL	1/19	0.09088251453617983	0.16534754257550138	0	0	11.15712682379349	26.75688382123247	FURIN
Calcineurin in effects in keratinocyte differentiation	1/19	0.09088251453617983	0.16534754257550138	0	0	11.15712682379349	26.75688382123247	CDKN1A
G-protein-independent seven transmembrane receptor signaling	1/19	0.09088251453617983	0.16534754257550138	0	0	11.15712682379349	26.75688382123247	MAPK14
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	1/19	0.09088251453617983	0.16534754257550138	0	0	11.15712682379349	26.75688382123247	CDKN2A
Lissencephaly gene (LIS1) in neuronal migration and development	1/19	0.09088251453617983	0.16534754257550138	0	0	11.15712682379349	26.75688382123247	NDEL1
Signaling by ERBB2	2/102	0.09248468910980343	0.16772142976826088	0	0	4.040816326530612	9.620020610565179	CDKN1A;HBEGF
GATA3-mediated activation of Th2 cytokine expression	1/20	0.09543241646248146	0.17110247843385595	0	0	10.569377990430622	24.83103038927071	MAPK14
Interleukin-3 regulation of hematopoietic cells	1/20	0.09543241646248146	0.17110247843385595	0	0	10.569377990430622	24.83103038927071	CXCL8
Nerve growth factor (NGF) pathway	1/20	0.09543241646248146	0.17110247843385595	0	0	10.569377990430622	24.83103038927071	JUN
Interleukin-4 signaling pathway	2/104	0.09556255444444083	0.17110247843385595	0	0	3.961184473789516	9.300759047174036	MAPK14;JAK3
Signaling by NGF	3/221	0.09912268730088447	0.17563025717859776	0	0	2.7923011444244774	6.454116294081024	CDKN1A;FURIN;MAPK14
Y branching of actin filaments	1/21	0.0999597740324998	0.17563025717859776	0	0	10.04040404040404	23.122924333288797	WASF1
p38 MK2 pathway	1/21	0.0999597740324998	0.17563025717859776	0	0	10.04040404040404	23.122924333288797	MAPK14
IGF1 signaling pathway	1/21	0.0999597740324998	0.17563025717859776	0	0	10.04040404040404	23.122924333288797	JUN
Mitochondrial role in apoptotic signaling	1/21	0.0999597740324998	0.17563025717859776	0	0	10.04040404040404	23.122924333288797	BIRC3
Nicotine activity on dopaminergic neurons	1/21	0.0999597740324998	0.17563025717859776	0	0	10.04040404040404	23.122924333288797	CHRNA3
Epstein-Barr virus LMP1 signaling	1/22	0.10446469781910508	0.18297543344712816	0	0	9.561808561808562	21.59922753970687	CXCL8
Leptin influence on immune response	2/110	0.10496798910782039	0.18328775807062136	0	0	3.739984882842026	8.430299329552396	CX3CR1;IFNG
RNA polymerase III transcription termination	1/23	0.10894729783603285	0.1862008363015834	0	0	9.1267217630854	20.232947516534363	POLR1D
CREB transcription factor and its extracellular signals	1/23	0.10894729783603285	0.1862008363015834	0	0	9.1267217630854	20.232947516534363	MAPK14
Th1/Th2 differentiation pathway	1/23	0.10894729783603285	0.1862008363015834	0	0	9.1267217630854	20.232947516534363	IFNG
Eicosanoid metabolism	1/23	0.10894729783603285	0.1862008363015834	0	0	9.1267217630854	20.232947516534363	EPHX2
Interleukin-11 pathway	1/23	0.10894729783603285	0.1862008363015834	0	0	9.1267217630854	20.232947516534363	JUN
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family	1/23	0.10894729783603285	0.1862008363015834	0	0	9.1267217630854	20.232947516534363	MAPK14
Modulation of interferon signaling by chaperones	1/23	0.10894729783603285	0.1862008363015834	0	0	9.1267217630854	20.232947516534363	IFNG
Inhibition of cellular proliferation by Gleevec	1/24	0.11340768358102403	0.1932384699084518	0	0	8.729468599033817	19.002011610155247	JUN
CXCR4 signaling pathway	2/116	0.11461325829541329	0.19470445083919607	0	0	3.5420694593626925	7.672801780572879	RHOC;PRKCZ
Phosphoinositides and their downstream targets	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	PRKCZ
Alpha-9 beta-1 integrin pathway	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	TGM2
RNA polymerase I transcription initiation	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	POLR1D
SHC1 events in ERBB2 signaling	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	HBEGF
C-Myc pathway	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	CDKN2A
Corticotropin releasing hormone pathway	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	CXCL8
TPO signaling pathway	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	JUN
G0 and early G1 pathway	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	MYBL2
Ghrelin pathway	1/25	0.11784596404042172	0.19491238627213447	0	0	8.365319865319865	17.88820673407011	CXCL8
Signaling by NOTCH	2/119	0.11951887729229536	0.19710130641185553	0	0	3.4507238792953077	7.330307004338375	JUN;FURIN
Disease	6/674	0.1216666600847961	0.19987219612338963	0	0	1.8376863294687222	3.8710316152397275	LDHB;CDKN1A;CXCL8;IGFBP3;RPL22;MFGE8
Interleukin-27-mediated signaling events	1/26	0.12226224762866918	0.19987219612338963	0	0	8.030303030303031	16.876380218002918	IFNG
Interleukin-9 regulation of target genes	1/26	0.12226224762866918	0.19987219612338963	0	0	8.030303030303031	16.876380218002918	CCL3
Rho GTPase cycle	2/123	0.1261397529272332	0.2029384836897563	0	0	3.3359757125990894	6.906686810673667	ARAP2;RHOC
RNA polymerase III transcription initiation from type 2 promoter	1/27	0.12665664230282664	0.2029384836897563	0	0	7.721056721056721	15.953830010816358	POLR1D
Cell cycle: G2/M checkpoint	1/27	0.12665664230282664	0.2029384836897563	0	0	7.721056721056721	15.953830010816358	CDKN1A
eIF4E and p70 S6 kinase regulation	1/27	0.12665664230282664	0.2029384836897563	0	0	7.721056721056721	15.953830010816358	MAPK14
FSH signaling pathway	1/27	0.12665664230282664	0.2029384836897563	0	0	7.721056721056721	15.953830010816358	MAPK14
Insulin regulation of blood glucose	1/27	0.12665664230282664	0.2029384836897563	0	0	7.721056721056721	15.953830010816358	PRKCZ
Oxidative stress	1/27	0.12665664230282664	0.2029384836897563	0	0	7.721056721056721	15.953830010816358	MAPK14
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation	1/28	0.1310292553948657	0.20605967094678257	0	0	7.434717545828657	15.109834134055738	FURIN
RNA polymerase III transcription initiation From type 3 promoter	1/28	0.1310292553948657	0.20605967094678257	0	0	7.434717545828657	15.109834134055738	POLR1D
TGF-beta receptor activation of SMADs	1/28	0.1310292553948657	0.20605967094678257	0	0	7.434717545828657	15.109834134055738	FURIN
Interleukin receptor SHC signaling	1/28	0.1310292553948657	0.20605967094678257	0	0	7.434717545828657	15.109834134055738	JAK3
PERK-regulated gene expression	1/28	0.1310292553948657	0.20605967094678257	0	0	7.434717545828657	15.109834134055738	CXCL8
SLC-mediated transmembrane transport	3/251	0.13116196127104565	0.20605967094678257	0	0	2.4507815098104424	4.978327314286831	SLC22A4;SLC2A1;SLC16A10
Neurotrophin signaling pathway	2/126	0.13116209551399813	0.20605967094678257	0	0	3.2547728768926927	6.611489635394594	JUN;MAPK14
ADP-ribosylation factor	1/29	0.13538019382269004	0.20805021611988334	0	0	7.1688311688311686	14.335283778329618	ARAP2
RNA polymerase	1/29	0.13538019382269004	0.20805021611988334	0	0	7.1688311688311686	14.335283778329618	POLR1D
Sema4D in semaphorin signaling	1/29	0.13538019382269004	0.20805021611988334	0	0	7.1688311688311686	14.335283778329618	RHOC
CDO in myogenesis	1/29	0.13538019382269004	0.20805021611988334	0	0	7.1688311688311686	14.335283778329618	MAPK14
Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK)	1/29	0.13538019382269004	0.20805021611988334	0	0	7.1688311688311686	14.335283778329618	MAPK14
IGF1 pathway	1/29	0.13538019382269004	0.20805021611988334	0	0	7.1688311688311686	14.335283778329618	PRKCZ
Influence of Ras and Rho proteins on G1 to S transition	1/29	0.13538019382269004	0.20805021611988334	0	0	7.1688311688311686	14.335283778329618	CDKN1A
Integrin beta-2 pathway	1/29	0.13538019382269004	0.20805021611988334	0	0	7.1688311688311686	14.335283778329618	PLAU
Cell-cell communication	2/129	0.13623023037232268	0.20822181552842817	0	0	3.177406395629118	6.333870360024791	SIRPG;MAPK14
PDGFB signaling pathway	2/129	0.13623023037232268	0.20822181552842817	0	0	3.177406395629118	6.333870360024791	JUN;PPP2R2B
Activation of matrix metalloproteinases	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	FURIN
Retinoic acid receptor-mediated signaling	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	MAPK14
Signaling pathway from G-protein families	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	JUN
p38-alpha and p38-beta regulation	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	MAPK14
Interferon-beta enhancer pathway	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	JUN
Interleukin-2/STAT5 pathway	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	JAK3
MicroRNAs in muscle cell differentiation	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	PRKCZ
Ovarian infertility genes	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	EGR1
PDGFA signaling pathway	1/30	0.13970956391884184	0.20845553981541481	0	0	6.921281783350749	13.622394510819323	JUN
Adipogenesis	2/133	0.14305475383730862	0.21152566126755085	0	0	3.07976320299112	5.988685251990531	CDKN1A;SERPINE1
Tight junction	2/133	0.14305475383730862	0.21152566126755085	0	0	3.07976320299112	5.988685251990531	PPP2R2B;PRKCZ
Alpha-6 beta-4 integrin signaling pathway	1/31	0.14401747150131122	0.21152566126755085	0	0	6.69023569023569	12.964476920040203	MAPK14
Amino acid transport across the plasma membrane	1/31	0.14401747150131122	0.21152566126755085	0	0	6.69023569023569	12.964476920040203	SLC16A10
Ras family activation regulation	1/31	0.14401747150131122	0.21152566126755085	0	0	6.69023569023569	12.964476920040203	PRKCZ
Signal amplification	1/31	0.14401747150131122	0.21152566126755085	0	0	6.69023569023569	12.964476920040203	MAPK14
NGF signaling via TRKA from the plasma membrane	2/136	0.14822032377707736	0.2155759494091844	0	0	3.0103563813585135	5.746937220227204	CDKN1A;MAPK14
Serotonin HTR1 group and FOS pathway	1/32	0.14830402193397793	0.2155759494091844	0	0	6.474095796676441	12.355752978101908	MAPK14
Syndecan 4 pathway	1/32	0.14830402193397793	0.2155759494091844	0	0	6.474095796676441	12.355752978101908	THBS1
Glycine, serine and threonine metabolism	1/32	0.14830402193397793	0.2155759494091844	0	0	6.474095796676441	12.355752978101908	PHGDH
Adrenergic pathway	2/137	0.14995070808433184	0.21685179322964912	0	0	2.9879062736205593	5.669398730173793	MAPK14;PRKCZ
Diabetes pathways	2/137	0.14995070808433184	0.21685179322964912	0	0	2.9879062736205593	5.669398730173793	CXCL8;IGFBP3
Propanoate metabolism	1/33	0.15256931999718407	0.21839872202642593	0	0	6.271464646464646	11.79120788980768	LDHB
Syndecan 2 pathway	1/33	0.15256931999718407	0.21839872202642593	0	0	6.271464646464646	11.79120788980768	CXCL8
Glycoprotein VI-mediated activation cascade	1/33	0.15256931999718407	0.21839872202642593	0	0	6.271464646464646	11.79120788980768	PRKCZ
Negative regulators of RIG-I/MDA5 signaling	1/33	0.15256931999718407	0.21839872202642593	0	0	6.271464646464646	11.79120788980768	UBE2L6
Systemic lupus erythematosus	2/139	0.1534237633251	0.219065829152801	0	0	2.9439892745419334	5.518659484645247	IFNG;FCGR1A
Cysteine and methionine metabolism	1/34	0.1568134700259566	0.22055560372728064	0	0	6.081114172023263	11.266469699963471	LDHB
TOR signaling	1/34	0.1568134700259566	0.22055560372728064	0	0	6.081114172023263	11.266469699963471	PRR5L
EGF receptor transactivation by GPCRs in cardiac hypertrophy	1/34	0.1568134700259566	0.22055560372728064	0	0	6.081114172023263	11.266469699963471	JUN
EPO receptor signaling	1/34	0.1568134700259566	0.22055560372728064	0	0	6.081114172023263	11.266469699963471	JUN
Induction of apoptosis through DR3 and DR4/5 death receptors	1/34	0.1568134700259566	0.22055560372728064	0	0	6.081114172023263	11.266469699963471	BIRC3
Monoamine transport	1/34	0.1568134700259566	0.22055560372728064	0	0	6.081114172023263	11.266469699963471	MAPK14
Primary immunodeficiency	1/35	0.16103657577419495	0.22315633596227505	0	0	5.901960784313726	10.777710825180796	JAK3
Prion diseases	1/35	0.16103657577419495	0.22315633596227505	0	0	5.901960784313726	10.777710825180796	EGR1
Arf6 signal transduction regulation	1/35	0.16103657577419495	0.22315633596227505	0	0	5.901960784313726	10.777710825180796	ARAP2
fMLP induced chemokine gene expression in HMC-1 cells	1/35	0.16103657577419495	0.22315633596227505	0	0	5.901960784313726	10.777710825180796	MAPK14
Interleukin-7 signaling pathway	1/35	0.16103657577419495	0.22315633596227505	0	0	5.901960784313726	10.777710825180796	JAK3
PIK3C1/AKT pathway	1/35	0.16103657577419495	0.22315633596227505	0	0	5.901960784313726	10.777710825180796	CDKN1A
Signaling to ERKs	1/36	0.16523874056701404	0.22730402360925833	0	0	5.733044733044733	10.321566994169176	MAPK14
Glycogen metabolism	1/36	0.16523874056701404	0.22730402360925833	0	0	5.733044733044733	10.321566994169176	PPP2R2B
PI3K/PLC/TRK pathway	1/36	0.16523874056701404	0.22730402360925833	0	0	5.733044733044733	10.321566994169176	EGR1
ALK in cardiac myocytes	1/37	0.16942006718012562	0.23136299731135798	0	0	5.57351290684624	9.895070145641316	TGFBR3
Allograft rejection	1/37	0.16942006718012562	0.23136299731135798	0	0	5.57351290684624	9.895070145641316	IFNG
PI3K/AKT activation	1/37	0.16942006718012562	0.23136299731135798	0	0	5.57351290684624	9.895070145641316	CDKN1A
BMAL1-CLOCK/NPAS2 activates circadian expression	1/38	0.17358065793162564	0.23533531508037708	0	0	5.422604422604422	9.495592558231127	SERPINE1
Signaling of hepatocyte growth factor receptor	1/38	0.17358065793162564	0.23533531508037708	0	0	5.422604422604422	9.495592558231127	JUN
ERBB4 signaling events	1/38	0.17358065793162564	0.23533531508037708	0	0	5.422604422604422	9.495592558231127	HBEGF
Signaling events regulated by Ret tyrosine kinase	1/39	0.17772061456847035	0.23922297521865699	0	0	5.279638490164806	9.12080010262218	JUN
FAS pathway and stress induction of heat shock protein regulation	1/39	0.17772061456847035	0.23922297521865699	0	0	5.279638490164806	9.12080010262218	JUN
GAB1 signalosome	1/39	0.17772061456847035	0.23922297521865699	0	0	5.279638490164806	9.12080010262218	CDKN1A
Phagosome	2/154	0.17993232146379678	0.2416234031085271	0	0	2.651450053705693	4.547699495381422	FCGR1A;THBS1
Pyruvate metabolism and citric acid (TCA) cycle	1/40	0.18184003844564067	0.24245338459418755	0	0	5.144004144004144	8.768612919919887	LDHB
Nuclear signaling by ErbB4	1/40	0.18184003844564067	0.24245338459418755	0	0	5.144004144004144	8.768612919919887	HBEGF
PAC1 receptor pathway	1/40	0.18184003844564067	0.24245338459418755	0	0	5.144004144004144	8.768612919919887	PRKCZ
Plasma membrane estrogen receptor signaling	1/41	0.1859390303366049	0.24617280072733605	0	0	5.015151515151516	8.43717221072756	HBEGF
Bioactive peptide-induced signaling pathway	1/41	0.1859390303366049	0.24617280072733605	0	0	5.015151515151516	8.43717221072756	MAPK14
Fc epsilon receptor I signaling in mast cells	1/41	0.1859390303366049	0.24617280072733605	0	0	5.015151515151516	8.43717221072756	JUN
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP)	1/42	0.1900176905858975	0.2498134673436974	0	0	4.892584380389258	8.124812043283224	JAK3
Eukaryotic transcription initiation	1/42	0.1900176905858975	0.2498134673436974	0	0	4.892584380389258	8.124812043283224	POLR1D
Hexose transport	1/42	0.1900176905858975	0.2498134673436974	0	0	4.892584380389258	8.124812043283224	SLC2A1
Type 1 diabetes mellitus	1/43	0.19407611900781976	0.2527919887307398	0	0	4.775853775853776	7.830035336967146	IFNG
Voltage-gated potassium channels	1/43	0.19407611900781976	0.2527919887307398	0	0	4.775853775853776	7.830035336967146	KCNH7
Mitotic prometaphase	1/43	0.19407611900781976	0.2527919887307398	0	0	4.775853775853776	7.830035336967146	NDEL1
PI3K class IB pathway in neutrophils	1/43	0.19407611900781976	0.2527919887307398	0	0	4.775853775853776	7.830035336967146	PRKCZ
ERBB2/ERBB3 signaling events	1/44	0.19811441496549978	0.25686558630009626	0	0	4.664552501761804	7.551493311263548	JUN
HNF3A pathway	1/44	0.19811441496549978	0.25686558630009626	0	0	4.664552501761804	7.551493311263548	JUN
RNA polymerase III transcription	1/45	0.20213267727917436	0.2602804337567451	0	0	4.558310376492194	7.287967841732019	POLR1D
Integrin-linked kinase signaling	1/45	0.20213267727917436	0.2602804337567451	0	0	4.558310376492194	7.287967841732019	JUN
Interleukin-3, interleukin-5, and GM-CSF signaling	1/45	0.20213267727917436	0.2602804337567451	0	0	4.558310376492194	7.287967841732019	JAK3
Alzheimer's disease	2/169	0.20707400097368484	0.26603584635343563	0	0	2.4114627887082976	3.7972799500547754	MME;APOE
Agrin in postsynaptic differentiation	1/47	0.2101094941683413	0.2693221697976011	0	0	4.359683794466403	6.801658146757973	JUN
Presenilin action in Notch and Wnt signaling	1/48	0.2140682440880332	0.27315495399468487	0	0	4.266709649688373	6.576964036635908	JUN
Energy metabolism	1/48	0.2140682440880332	0.27315495399468487	0	0	4.266709649688373	6.576964036635908	MAPK14
Amino acid and oligopeptide SLC transporters	1/49	0.21800735103248006	0.2769282567169341	0	0	4.177609427609427	6.363445371866637	SLC16A10
Interleukin-5 signaling pathway	1/49	0.21800735103248006	0.2769282567169341	0	0	4.177609427609427	6.363445371866637	JUN
Type 2 diabetes mellitus	1/50	0.22192691156038513	0.28127365869675774	0	0	4.092145949288806	6.1603458876211565	PRKCZ
Amyloids	1/51	0.22582702165646545	0.28493610786184903	0	0	4.01010101010101	5.966974015935645	MFGE8
Metabolism of vitamins and cofactors	1/51	0.22582702165646545	0.28493610786184903	0	0	4.01010101010101	5.966974015935645	SLC2A1
Lipid and lipoprotein metabolism	4/489	0.22895017916342633	0.287900413610626	0	0	1.6679553264604812	2.458984570031573	APOE;ANGPTL4;LDLRAP1;LDLR
Pyruvate metabolism	1/52	0.22970777681698884	0.287900413610626	0	0	3.9312735195088138	5.782696221966044	LDHB
Interleukin-2 receptor beta chain in T cell activation	1/52	0.22970777681698884	0.287900413610626	0	0	3.9312735195088138	5.782696221966044	JAK3
Amyotrophic lateral sclerosis (ALS)	1/53	0.23356927222454107	0.2914448441031884	0	0	3.8554778554778553	5.606931137649977	MAPK14
JNK/MAPK pathway	1/53	0.23356927222454107	0.2914448441031884	0	0	3.8554778554778553	5.606931137649977	JUN
Arginine and proline metabolism	1/54	0.23741160244685378	0.2942860302857704	0	0	3.7825424051839147	5.43914439332398	AGMAT
Kit receptor signaling pathway	1/54	0.23741160244685378	0.2942860302857704	0	0	3.7825424051839147	5.43914439332398	MAPK14
Non-small cell lung cancer	1/54	0.23741160244685378	0.2942860302857704	0	0	3.7825424051839147	5.43914439332398	CDKN2A
RNA polymerase I transcription	1/55	0.2412348616553018	0.29836943415261014	0	0	3.7123082678638233	5.278844037828421	POLR1D
Pathogenic Escherichia coli infection	1/57	0.24882454141300062	0.3050805246889834	0	0	3.5793650793650795	4.978922896997587	TLR5
Acute myeloid leukemia	1/57	0.24882454141300062	0.3050805246889834	0	0	3.5793650793650795	4.978922896997587	FLT3
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	1/57	0.24882454141300062	0.3050805246889834	0	0	3.5793650793650795	4.978922896997587	JUN
PI3K cascade	1/57	0.24882454141300062	0.3050805246889834	0	0	3.5793650793650795	4.978922896997587	CDKN1A
Arachidonic acid metabolism	1/58	0.2525911479606718	0.30835802478315777	0	0	3.5163919900762006	4.8384959983786695	EPHX2
HIV-1 Nef as negative effector of Fas and TNF	1/58	0.2525911479606718	0.30835802478315777	0	0	3.5163919900762006	4.8384959983786695	BIRC3
Amino acid metabolism	2/195	0.25496327735006236	0.3105816164696224	0	0	2.0838532304113353	2.8478683319899094	PHGDH;AGMAT
Caspase cascade in apoptosis	1/59	0.25633905564263204	0.3115845417725096	0	0	3.4555903866248694	4.703937185372145	BIRC3
Natural killer cell receptor signaling pathway	1/60	0.26006835626766184	0.3147608432080714	0	0	3.396849854476973	4.574913980988086	MAPK14
Neurotrophic factor-mediated Trk receptor signaling	1/60	0.26006835626766184	0.3147608432080714	0	0	3.396849854476973	4.574913980988086	PRKCZ
Androgen receptor proteolysis and transcription regulation	1/61	0.26377914130867525	0.31788768311558296	0	0	3.34006734006734	4.4511177340934625	CDKN2A
Leptin signaling pathway	1/61	0.26377914130867525	0.31788768311558296	0	0	3.34006734006734	4.4511177340934625	MAPK14
Signaling events mediated by focal adhesion kinase	1/62	0.2674715018007107	0.32028434610530965	0	0	3.2851465474416295	4.3322615615299345	JUN
Circadian rhythm	1/62	0.2674715018007107	0.32028434610530965	0	0	3.2851465474416295	4.3322615615299345	SERPINE1
Colorectal cancer	1/62	0.2674715018007107	0.32028434610530965	0	0	3.2851465474416295	4.3322615615299345	JUN
Proteasome degradation	1/63	0.2711455282609312	0.32399592783721437	0	0	3.231997393287716	4.218078497375417	IFNG
Validated nuclear estrogen receptor alpha network	1/64	0.2748013108427819	0.3262903985585874	0	0	3.1805355138688474	4.108319823136149	JUN
Interferon alpha/beta signaling	1/64	0.2748013108427819	0.3262903985585874	0	0	3.1805355138688474	4.108319823136149	EGR1
MAPK cascade role in angiogenesis	1/64	0.2748013108427819	0.3262903985585874	0	0	3.1805355138688474	4.108319823136149	MAPK14
DNA replication	2/207	0.2771996724711015	0.3284466707430698	0	0	1.9606769537083126	2.515582241975174	CDKN1A;NDEL1
Semaphorin interactions	1/66	0.28205850257636833	0.332110637689085	0	0	3.0823620823620823	3.9011631304837175	RHOC
Destabilization of mRNA by AUF1 (hnRNP D0)	1/66	0.28205850257636833	0.332110637689085	0	0	3.0823620823620823	3.9011631304837175	FCGR1A
Endochondral ossification	1/66	0.28205850257636833	0.332110637689085	0	0	3.0823620823620823	3.9011631304837175	PLAU
Adipocytokine signaling pathway	1/67	0.28566008980872587	0.33425786442348837	0	0	3.0355065809611266	3.8033460819667058	SLC2A1
SIDS susceptibility pathways	1/67	0.28566008980872587	0.33425786442348837	0	0	3.0355065809611266	3.8033460819667058	CXCL8
G alpha 13 pathway	1/67	0.28566008980872587	0.33425786442348837	0	0	3.0355065809611266	3.8033460819667058	PRKCZ
AMPK signaling	1/68	0.2892437892552286	0.3377505116769129	0	0	2.990049751243781	3.7091130169332227	CDKN1A
PPAR signaling pathway	1/69	0.2928096888806698	0.34120798456342516	0	0	2.9459298871063577	3.6182865561027495	ANGPTL4
Pancreatic cancer	1/70	0.29635787620352466	0.3425119716778441	0	0	2.9030888596105986	3.530700422312052	CDKN2A
Signaling events mediated by VEGFR1 and VEGFR2	1/70	0.29635787620352466	0.3425119716778441	0	0	2.9030888596105986	3.530700422312052	MAPK14
G alpha q pathway	1/70	0.29635787620352466	0.3425119716778441	0	0	2.9030888596105986	3.530700422312052	PRKCZ
MicroRNA regulation of DNA damage response	1/70	0.29635787620352466	0.3425119716778441	0	0	2.9030888596105986	3.530700422312052	CDKN1A
Bacterial invasion of epithelial cells	1/71	0.2998884383134025	0.34588359756392434	0	0	2.8614718614718613	3.446198601550195	WASF1
Cyclin A-Cdk2-associated events at S phase entry	1/72	0.30340146185965494	0.34851002950885007	0	0	2.821027173139849	3.3646345783285243	CDKN1A
Myocyte adrenergic pathway	1/72	0.30340146185965494	0.34851002950885007	0	0	2.821027173139849	3.3646345783285243	MAPK14
Cap-dependent translation initiation	1/73	0.30689703311188365	0.35180879405508614	0	0	2.781705948372615	3.2858706369655613	RPL22
Adherens junction cell adhesion	1/74	0.31037523789289684	0.35363966499311883	0	0	2.74346201743462	3.209777224050686	WASF1
Wnt/calcium/cyclic GMP pathway	1/74	0.31037523789289684	0.35363966499311883	0	0	2.74346201743462	3.209777224050686	PRKCZ
Integrins in angiogenesis	1/74	0.31037523789289684	0.35363966499311883	0	0	2.74346201743462	3.209777224050686	MFGE8
RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways	1/76	0.31727988935066437	0.3600520273516594	0	0	2.67003367003367	3.0651211233087037	UBE2L6
VEGF signaling pathway	1/76	0.31727988935066437	0.3600520273516594	0	0	2.67003367003367	3.0651211233087037	MAPK14
Transcriptional regulation of white adipocyte differentiation	1/77	0.3207065055587057	0.3624819020743688	0	0	2.6347687400318978	2.996335121708695	ANGPTL4
G alpha (12/13) signaling events	1/77	0.3207065055587057	0.3624819020743688	0	0	2.6347687400318978	2.996335121708695	RHOC
Peroxisome	1/78	0.32411609442991285	0.3648732081007402	0	0	2.600419782237964	2.929772078325152	EPHX2
Signaling by SCF-KIT	1/78	0.32411609442991285	0.3648732081007402	0	0	2.600419782237964	2.929772078325152	CDKN1A
Antigen processing: cross presentation	1/79	0.32750873980152984	0.36649787549218815	0	0	2.566951566951567	2.865335397718705	FCGR1A
Unfolded protein response	1/79	0.32750873980152984	0.36649787549218815	0	0	2.566951566951567	2.865335397718705	CXCL8
Fc epsilon receptor I signaling pathway	1/79	0.32750873980152984	0.36649787549218815	0	0	2.566951566951567	2.865335397718705	MAPK14
GPCR ligand binding	3/410	0.3370045010599002	0.3762814568774131	0	0	1.481268522505636	1.6111150287484346	CX3CR1;CXCL8;CCL3
Platelet homeostasis	1/82	0.3375858460637784	0.3762814568774131	0	0	2.471505175208879	2.6838950656014107	MAPK14
ECM-receptor interaction	1/84	0.34422071652682057	0.3829200870239187	0	0	2.4117074358038213	2.572018957842433	THBS1
Integrin cell surface interactions	1/85	0.34751343686607217	0.3843089772401269	0	0	2.382876382876383	2.5185858334956643	THBS1
MicroRNAs in cardiomyocyte hypertrophy	1/85	0.34751343686607217	0.3843089772401269	0	0	2.382876382876383	2.5185858334956643	MAPK14
Myc active pathway	1/85	0.34751343686607217	0.3843089772401269	0	0	2.382876382876383	2.5185858334956643	SLC2A1
Progesterone-mediated oocyte maturation	1/86	0.3507897886854045	0.3856636273266435	0	0	2.354723707664884	2.46673350535558	MAPK14
mRNA stability regulation by proteins that bind AU-rich elements	1/86	0.3507897886854045	0.3856636273266435	0	0	2.354723707664884	2.46673350535558	MAPK14
Non-class A, B, C GPCRs	1/86	0.3507897886854045	0.3856636273266435	0	0	2.354723707664884	2.46673350535558	CELSR2
DNA replication pre-Initiation	1/88	0.35729370848339814	0.3920499058066859	0	0	2.3003599210495764	2.367523811703655	CDKN1A
Prostate cancer	1/89	0.3605214364245345	0.3948234760066747	0	0	2.2741046831955924	2.32005037808893	CDKN1A
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	2/255	0.36515588544926686	0.3991238747933847	0	0	1.5848189078002743	1.5965955911608378	UBE2L6;FCGR1A
Transmembrane transport of small molecules	3/432	0.36709782346349296	0.400470352869265	0	0	1.4037199913488574	1.406705587961562	SLC22A4;SLC2A1;SLC16A10
Extracellular matrix organization	1/93	0.3732726494349856	0.4064204136705249	0	0	2.1747913921826965	2.1431398321634836	FURIN
Cell surface interactions at the vascular wall	1/94	0.3764209201158763	0.40905857214904473	0	0	2.1512979254914737	2.101919815261755	SIRPG
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	1/95	0.37955353321698265	0.4100923232459353	0	0	2.1283043197936813	2.061815304518316	POLR1D
Transport of inorganic cations/anions and amino acids/oligopeptides	1/95	0.37955353321698265	0.4100923232459353	0	0	2.1283043197936813	2.061815304518316	SLC16A10
G-protein signaling pathways	1/95	0.37955353321698265	0.4100923232459353	0	0	2.1283043197936813	2.061815304518316	PRKCZ
M phase pathway	1/96	0.38267056588073545	0.41266959685800153	0	0	2.105794790005316	2.022786046627892	NDEL1
Downstream signaling events Of B cell receptor (BCR)	1/98	0.38885819639751296	0.4185420281835826	0	0	2.062168072477351	1.947801335478516	CDKN1A
Potassium channels	1/99	0.39192894652386845	0.42024320501798823	0	0	2.0410224695938983	1.9117741389719494	KCNH7
Granule cell survival pathway	1/99	0.39192894652386845	0.42024320501798823	0	0	2.0410224695938983	1.9117741389719494	JUN
Neuronal system	2/283	0.4146970622204942	0.44381241573502606	0	0	1.4248674558791488	1.254178302841909	CHRNA3;KCNH7
Cytoplasmic ribosomal proteins	1/108	0.41888723576300985	0.44744772911048775	0	0	1.8684980647597471	1.6258801725332535	RPL22
Signaling by interleukins	1/109	0.42180856913936493	0.44971650849641176	0	0	1.8511036288814067	1.5978794932003777	JAK3
Signaling by EGFR in cancer	1/111	0.4276076879640406	0.455039124550413	0	0	1.8172635445362717	1.5438546462627225	CDKN1A
S phase	1/112	0.43048561638067023	0.4563794880426654	0	0	1.8008008008008007	1.5177894088208939	CDKN1A
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	1/112	0.43048561638067023	0.4563794880426654	0	0	1.8008008008008007	1.5177894088208939	ANGPTL4
Cell cycle checkpoints	1/117	0.4446617754820939	0.4687649371437401	0	0	1.7227446882619297	1.396183515184437	CDKN1A
Tricarboxylic acid (TCA) cycle and respiratory electron transport	1/117	0.4446617754820939	0.4687649371437401	0	0	1.7227446882619297	1.396183515184437	LDHB
Leukocyte transendothelial migration	1/117	0.4446617754820939	0.4687649371437401	0	0	1.7227446882619297	1.396183515184437	MAPK14
G alpha s pathway	1/120	0.45299919523566695	0.47666333230021674	0	0	1.6790595025889143	1.3295883355209954	MAPK14
Influenza viral RNA transcription and replication	1/125	0.4666203770761902	0.48917080422113624	0	0	1.6109481915933528	1.2279279396515803	RPL22
Integration of energy metabolism	1/125	0.4666203770761902	0.48917080422113624	0	0	1.6109481915933528	1.2279279396515803	SLC2A1
Spliceosome	1/127	0.47197433920713694	0.4938655423243511	0	0	1.5852172518839185	1.1902297169988543	HSPA1B
Signaling by FGFR in disease	1/128	0.47463133363816096	0.4957260595776348	0	0	1.572655690765927	1.171969623816576	CDKN1A
Parkinson's disease	1/131	0.4825231566060633	0.5030370800846945	0	0	1.5361305361305362	1.1194188238932659	UBE2L6
Influenza infection	1/142	0.5104686592356167	0.5311887893152911	0	0	1.4155025431621175	0.9518207634132154	RPL22
Calcium regulation in the cardiac cell	1/149	0.5274687471502818	0.5478680909627236	0	0	1.348075348075348	0.8623175106205572	PRKCZ
Signaling by the B cell receptor (BCR)	1/151	0.5322176434695001	0.5507720200308222	0	0	1.32996632996633	0.8388134470328799	CDKN1A
Translation	1/151	0.5322176434695001	0.5507720200308222	0	0	1.32996632996633	0.8388134470328799	RPL22
Integrated breast cancer pathway	1/152	0.5345743423067151	0.5517697760488391	0	0	1.3210917118201886	0.8273792233748533	JUN
Gene expression	5/968	0.5351384175509131	0.5517697760488391	0	0	1.0349784117614909	0.6470993879847858	CDKN2B;SERPINE1;RPL22;POLR1D;MAPK14
Signaling by GPCR	5/977	0.5434689742398218	0.5593366815168969	0	0	1.0249079488845572	0.6249710944707999	CX3CR1;CXCL8;CCL3;RHOC;HBEGF
Generic transcription pathway	2/377	0.5650100141620913	0.5804474462430228	0	0	1.0625850340136054	0.6066423597241232	CDKN2B;SERPINE1
Protein processing in the endoplasmic reticulum	1/166	0.566359876814798	0.580776310042811	0	0	1.2081420263238445	0.6868596439049133	HSPA1B
Fatty acid, triacylglycerol, and ketone body metabolism	1/173	0.5814369585683391	0.5951550719283907	0	0	1.1585623678646935	0.6282336006501239	ANGPTL4
Metapathway biotransformation	1/174	0.58354802824362	0.5962338549445683	0	0	1.1518070882232732	0.6203961472877585	EPHX2
Transcription	1/181	0.5980332540921672	0.6099290331066588	0	0	1.10662177328844	0.5689241221993853	POLR1D
Huntington's disease	1/184	0.6040874563472056	0.614991562057444	0	0	1.088314842413203	0.5485501823263738	TGM2
Transmission across chemical synapses	1/190	0.6159263323660239	0.6259143269449324	0	0	1.0534444978889423	0.5105286083837139	CHRNA3
Post-translational protein modification	1/196	0.6274146268959372	0.6364421754843679	0	0	1.0207200207200207	0.4758062593684267	FURIN
G alpha (i) signaling events	1/199	0.6330305302852147	0.6409860306658188	0	0	1.0051015202530353	0.4595692288153314	CXCL8
Messenger RNA processing	1/203	0.6403882389034606	0.6472741339454333	0	0	0.984998499849985	0.43899478472648823	CLK1
Gastrin-CREB signaling pathway via PKC and MAPK	1/206	0.6458104997913089	0.6515869801114458	0	0	0.9704360679970436	0.4243223577096833	HBEGF
Protein metabolism	2/442	0.6518647281175962	0.6565209047470076	0	0	0.9025974025974026	0.38623786558597684	RPL22;FURIN
Actin cytoskeleton regulation	1/226	0.6799469058224439	0.6835829855327243	0	0	0.8832772166105499	0.3407158512914232	WASF1
Carbohydrate metabolism	1/235	0.6942254521812744	0.696696005391884	0	0	0.8489165155831823	0.30981930849208233	SLC2A1
Class A GPCRs (rhodopsin-like)	1/253	0.7209173773938783	0.7221978700713096	0	0	0.7875581208914543	0.2577132288378451	CX3CR1
Neuroactive ligand-receptor interaction	1/272	0.7465915273403464	0.7465915273403464	0	0	0.7316336799731634	0.2138104762844621	CHRNA3
